Predicting Progression in CKD: Perspectives and Precautions

American Journal of Kidney Diseases

Volumn 67, Issue 5, 2016, Pages 779-786

  Kadatz, Matthew James ^a   Lee, Elizabeth Sunmin ^a   Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

biomarkers; chronic kidney disease (CKD); decision making; disease progression; Index Words Prediction models; outcomes; prognosis; review; risk calculator; risk equation; risk prediction tool; usefulness; validity

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYSTATIN C; FIBROBLAST GROWTH FACTOR 23; TROPONIN;

ANALYTIC METHOD; CALIBRATION; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CREATININE URINE LEVEL; DISEASE COURSE; EXTERNAL VALIDITY; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HUMAN; INTERNAL VALIDITY; NEPHROLOGY; NET RECLASSIFICATION INDEX; NONBIOLOGICAL MODEL; PREDICTION; RENAL SYSTEM PARAMETERS; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC); URINARY ALBUMIN CREATININE RATIO; ALBUMINURIA; BLOOD; CHRONIC KIDNEY FAILURE; DECISION SUPPORT SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; URINE;

ALBUMINURIA; BIOMARKERS; CLINICAL DECISION-MAKING; CREATININE; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84963954546     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.11.007     Document Type: Review

References (48)

1. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 6 2006 565 574
2. B.M. Reilly, and A.T. Evans Translating clinical research into clinical practice: impact of using prediction rules to make decisions Ann Intern Med 144 3 2006 201 209
3. G.S. Collins, J.B. Reitsma, D.G. Altman, and K.G. Moons Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement BMJ 350 2015 g7594
4. E.W. Steyerberg, A.J. Vickers, N.R. Cook, and et al. Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 1 2010 128 138
5. D.W. Hosmer, T. Hosmer, S. Le Cessie, and S. Lemeshow A comparison of goodness-of-fit tests for the logistic regression model Stat Med 16 9 1997 965 980
6. J. Hilden, and T.A. Gerds A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index Stat Med 33 19 2014 3405 3414
7. A.J. Vickers, and M. Pepe Does the net reclassification improvement help us evaluate models and markers? Ann Intern Med 160 2 2014 136 137
8. A.J. Vickers, and A.M. Cronin Everything you always wanted to know about evaluating prediction models (but were too afraid to ask) Urology 76 6 2010 1298 1301
9. N. Tangri, G.D. Kitsios, L.A. Inker, and et al. Risk prediction models for patients with chronic kidney disease: a systematic review Ann Intern Med 158 8 2013 596 603
10. G.S. Collins, O. Omar, M. Shanyinde, and L.M. Yu A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods J Clin Epidemiol 66 3 2013 268 277
11. C. Rigatto, M.M. Sood, and N. Tangri Risk prediction in chronic kidney disease: pitfalls and caveats Curr Opin Nephrol Hypertens 21 6 2012 612 618
12. J.B. Echouffo-Tcheugui, and A.P. Kengne Risk models to predict chronic kidney disease and its progression: a systematic review PLoS Med 9 11 2012 e1001344
13. H. Bang, S. Vupputuri, D.A. Shoham, and et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease Arch Intern Med 167 4 2007 374 381
14. M.W. Taal Predicting renal risk in the general population: do we have the right formula? Clin J Am Soc Nephrol 6 7 2011 1523 1525
15. B.M. Brenner, M.E. Cooper, D. de Zeeuw, and et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 2001 861 869
16. N. Tangri, L.A. Stevens, J. Griffith, and et al. A predictive model for progression of chronic kidney disease to kidney failure JAMA 305 15 2011 1553 1559
17. C.Y. Hsu, K. Propert, D. Xie, and et al. Measured GFR does not outperform estimated GFR in predicting CKD-related complications J Am Soc Nephrol 22 10 2011 1931 1937
18. D.E. Weiner, H. Tighiouart, E.F. Elsayed, and et al. The Framingham predictive instrument in chronic kidney disease J Am Coll Cardiol 50 3 2007 217 224
19. A. Levin, D.G. Warnock, R.L. Mehta, and et al. Improving outcomes from acute kidney injury: report of an initiative Am J Kidney Dis 50 1 2007 1 4
20. A.S. Levey, and J. Coresh Chronic kidney disease Lancet 379 9811 2012 165 180
21. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
22. G.M. Chertow, S.H. Soroko, E.P. Paganini, and et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment Kidney Int 70 6 2006 1120 1126
23. E. Chapin, M. Zhan, V.D. Hsu, S.L. Seliger, L.D. Walker, and J.C. Fink Adverse safety events in chronic kidney disease: the frequency of "multiple hits." Clin J Am Soc Nephrol 5 1 2010 95 101
24. K. Iseki Gender differences in chronic kidney disease Kidney Int 74 4 2008 415 417
25. B.R. Hemmelgarn, J. Zhang, B.J. Manns, and et al. Progression of kidney dysfunction in the community-dwelling elderly Kidney Int 69 12 2006 2155 2161
26. A. Parsa, W.H. Kao, D. Xie, and et al. APOL1 risk variants, race, and progression of chronic kidney disease N Engl J Med 369 23 2013 2183 2196
27. S.J. Barbour, D.C. Cattran, S.J. Kim, and et al. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease Kidney Int 84 5 2013 1017 1024
28. K.G. Moons, D.G. Altman, Y. Vergouwe, and P. Royston Prognosis and prognostic research: application and impact of prognostic models in clinical practice BMJ 338 2009 b606
29. K.G. Moons, A.P. Kengne, D.E. Grobbee, and et al. Risk prediction models: II. External validation, model updating, and impact assessment Heart 98 9 2012 691 698
30. C.A. Peralta, M.G. Shlipak, S. Judd, and et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality JAMA 305 15 2011 1545 1552
31. A.S. Desai, R. Toto, P. Jarolim, and et al. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD Am J Kidney Dis 58 5 2011 717 728
32. T. Isakova Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease Curr Opin Nephrol Hypertens 21 3 2012 334 340
33. M.J. Pletcher, and M. Pignone Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact Circulation 123 10 2011 1116 1124
34. H.I. Feldman, L.J. Appel, G.M. Chertow, and et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods J Am Soc Nephrol 14 7 suppl 2 2003 S148 S153
35. E. Imai, S. Matsuo, H. Makino, and et al. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods Hypertens Res 31 6 2008 1101 1107
36. B. Gao, L. Zhang, H. Wang, and M. Zhao Chinese cohort study of chronic kidney disease: design and methods Chin Med J (Engl) 127 11 2014 2180 2185
37. K.U. Eckardt, B. Barthlein, S. Baid-Agrawal, and et al. The German Chronic Kidney Disease (GCKD) study: design and methods Nephrol Dial Transplant 27 4 2012 1454 1460
38. A. Levin, C. Rigatto, B. Brendan, and et al. Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT) BMC Nephrol 14 2013 121
39. S.K. Venuthurupalli, W.E. Hoy, H.G. Healy, A. Salisbury, R.G. Fassett, and C.Q. Group CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia Nephrol Dial Transplant 27 suppl 3 2012 iii139 iii145
40. S.S. Mahmood, D. Levy, R.S. Vasan, and T.J. Wang The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective Lancet 383 9921 2014 999 1008
41. T.H. Lee, E.R. Marcantonio, C.M. Mangione, and et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery Circulation 100 10 1999 1043 1049
42. B.F. Gage, C. van Walraven, L. Pearce, and et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin Circulation 110 16 2004 2287 2292
43. A.M. Arozullah, J. Daley, W.G. Henderson, and S.F. Khuri Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program Ann Surg 232 2 2000 242 253
44. R. Mehran, E.D. Aymong, E. Nikolsky, and et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 7 2004 1393 1399
45. J.A. Kanis, O. Johnell, A. Oden, H. Johansson, and E. McCloskey FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 4 2008 385 397
46. L.M. Cohen, R. Ruthazer, A.H. Moss, and M.J. Germain Predicting six-month mortality for patients who are on maintenance hemodialysis Clin J Am Soc Nephrol 5 1 2010 72 79
47. R.E. Paetzer iChoose Kidney Risk Calculator 2014 Emory University School of Medicine Atlanta, GA 2014 [October 2, 2015] http://www.ichoosekidney.emory.edu Accessed December 21, 2015
48. P.S. Rao, D.E. Schaubel, M.K. Guidinger, and et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index Transplantation 88 2 2009 231 236